MedTrace Logo

HDAC Activity in Peripheral Skeletal Muscle in COPD

NCT00180752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2016-02-19

No results posted yet for this study

Summary

We wish to study the effect of Chronic Obstructive Pulmonary Disease on the activity of the nuclear transcription pathway in peripheral skeletal muscle to determine whether altered activity of this pathway may be responsible for the muscle dysfunction observed in these patients.

Conditions

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Michael I Polkey, PhD · Royal Brompton & Harefield NHS Foundation Trust

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180752 on ClinicalTrials.gov